Gene editor may have cured infant of a deadly metabolic disorder
By Jocelyn Kaiser,
Science
| 01. 14. 2025
A little-known gene editor, tested with help from a disgraced gene therapist seeking redemption, may have cured a 1-year-old boy of a deadly metabolic disorder. Announced last week by a company developing the therapy, the result could be the first success at stitching a curative gene into a “safe harbor,” a specific chromosomal location where its integration is unlikely to disrupt existing DNA in a way that triggers cancer or other problems. Because the gene should now be integrated in the baby’s genome, in this case within cells of the boy’s liver, it should persist as the organ—and person—grows.
The gene editor, dubbed ARCUS, is a DNA-cutting enzyme known as a nuclease, It is in some ways simpler and potentially better than the more famous CRISPR platform and could also help treat other genetic metabolic disorders. The company, iECURE, will not present data for the treated infant until March. But the apparent success of the safe harbor approach with the editor in the very first patient who received it is especially significant for iECURE co-founder James Wilson, who helped develop...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...